Darryl Wellinghoff
No más puestos en curso
Perfil
Darryl Wellinghoff worked as the Chief Commercial Officer at La Jolla Pharmaceutical Co. from 2019 to 2020.
Prior to that, he was the Senior Vice President-Americas at The Medicines Co. from 2001 to 2016.
He also worked as the Executive Vice President at Mainstreet Investment Co. LLC from 2016 to 2018.
Mr. Wellinghoff completed his undergraduate degree from Florida State University.
Antiguos cargos conocidos de Darryl Wellinghoff.
| Empresas | Cargo | Fin |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 30/09/2020 |
Mainstreet Investment Co. LLC
 Mainstreet Investment Co. LLC Investment ManagersFinance Mainstreet Investment Co. LLC specializes in investments and health solutions. It offers real estate development and management services. The company was founded by Zeke Turner in 2002 and is headquartered in Carmel, IN. | Corporate Officer/Principal | 01/01/2018 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01/01/2016 |
Formación de Darryl Wellinghoff.
| Florida State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Mainstreet Investment Co. LLC
Mainstreet Investment Co. LLC Investment ManagersFinance Mainstreet Investment Co. LLC specializes in investments and health solutions. It offers real estate development and management services. The company was founded by Zeke Turner in 2002 and is headquartered in Carmel, IN. | Finance |
- Bolsa de valores
- Insiders
- Darryl Wellinghoff
